Author

Steve A. Seibold

University of KansasORCID 0000-0001-8297-229XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1 Assay:structural biology· 1

Frequent Co-Authors

K.P. BattaileiD· 2 shared S. LovelliD· 2 shared Alison RothiD· 1 shared Aminata MbayeiD· 1 shared Amy De Rocher· 1 shared Anusha Thaniana· 1 shared Avery ChiuiD· 1 shared Bart L. StakeriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

K.P. BattaileORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintAug 5, 2026

Structural analyses of Trichomonas vaginalis pyrophosphate-dependent phosphofructokinase (TvPPi-PFK)

Avery Chiu, Lijun Liu, Steve A. Seibold…·Oluwatoyin Ajibola Asojo

This paper reports the purification, crystallization, and structure of Trichomonas vaginalis pyrophosphate-dependent phosphofructokinase (TvPPi-PFK), revealing its active site and additional ligand-binding sites.

DOI 10.64898/2026.03.28.715000

humanstructural biology

𝕏 PostBluesky

MicrobiologybioRxivPreprintJul 9, 2025

An orally available PfPKG inhibitor blocks sporozoite infection of the liver

Hanna Dhiyebi, Aminata Mbaye, Anusha Thaniana…·Purnima Bhanot

This paper describes RUPB-61, an orally available PfPKG inhibitor that prevents liver infection by malaria sporozoites and shows activity against drug-resistant isolates.

DOI 10.1101/2025.07.09.663303

humanexperimental assay

𝕏 PostBluesky